Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial

Dendritic cells and the control of immunity

1998 • 14,345 citations

Cancer Statistics, 2002

2002 • 2,954 citations

Linear Mixed Models for Longitudinal Data

2000 • 2,599 citations

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

1999 • 994 citations

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

1999 • 907 citations

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells

2000 • 627 citations

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

2001 • 327 citations

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1993 • 314 citations

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

2000 • 300 citations

Dendritic cells: On the move from bench to bedside

2001 • 291 citations

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

1998 • 266 citations

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

2000 • 260 citations

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

2001 • 257 citations

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

1997 • 215 citations

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

2000 • 145 citations

Clinical Trials in Relapsed Prostate Cancer: Defining the Target

1996 • 129 citations

Dendritic Cell-Based Immunotherapy of Prostate Cancer

1998 • 95 citations

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

1999 • 69 citations

Transforming Growth Factor β as an Immunosuppressive Protein in Human Seminal Plasma

1993 • 67 citations

Systemic treatment for prostate cancer

1998 • 37 citations

Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.

1992 • 34 citations

Dendritic cell-based treatment of cancer: closing in on a cellular therapy.

2002 • 32 citations

Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia.

2001 • 14 citations